Medical technology company Stryker (NYSE: SYK) announced on Tuesday that it has received FDA 510k clearance for its Pangea Systems, which encompass Femur, Fibula, Tibia, Humerus and Utility plates.

Designed in collaboration with renowned orthopaedic surgeons, Pangea plates provide evidence-based design for precise implant fit. These plates enhance plate fit and screw placement, offering anatomically contoured implants for diverse fracture patterns. The system comprises 20 anatomic plates and 13 utility plates, all accessible within one platform.

Pangea Systems will be showcased at the Annual Orthopaedic Trauma Association meeting in Seattle from 18 to 21 October 2023, allowing attendees to explore the portfolio and engage with product experts.

Stryker is focused on enhancing healthcare through innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine. Its mission is to improve patient outcomes and impact over 130 million patients worldwide annually.